An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler;   Drug: Placebo inhalation powders via ELLIPTA inhaler;   Drug: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler;   Drug: Placebo inhalation powder via ACCUHALER/DISKUS inhaler;   Drug: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified November 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the … – MarketWatch

GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the
MarketWatch
20, 2014 /PRNewswire/ — GlaxoSmithKline plc today announced that the FDA has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic …

View full post on asthma – Google News

Once-Daily Fluticasone Furoate May Be Effective for Persistent Asthma – Monthly Prescribing Reference

Once-Daily Fluticasone Furoate May Be Effective for Persistent Asthma
Monthly Prescribing Reference
A new study published in the journal Respiratory Research evaluates the use of a once-daily dosing regimen for the inhaled corticosteroid (ICS) fluticasone furoate vs. placebo in patients with asthma uncontrolled by non-inhaled corticosteroids

View full post on asthma – Google News

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Condition:   Persistent Asthma
Interventions:   Drug: Fluticasone propionate Multidose Dry Powder Inhaler (Fp MDPI);   Drug: Fluticasone propionate /salmeterol MDPI (FS MDPI);   Drug: Fluticasone propionate HFA Inhalation Aerosol;   Drug: Fluticasone propionate/salmeterol dry powder formulation
Sponsors:   Teva Pharmaceutical Industries;   Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified June 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus

Condition:   Asthma
Interventions:   Drug: Seretide Diskus and charcoal;   Drug: Seretide Diskus;   Drug: SF Easyhaler and charcoal;   Drug: SF Easyhaler
Sponsors:   Orion Corporation, Orion Pharma;   Orion Corporation, Orion Pharma
Recruiting – verified May 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: Umeclidinium bromide/Vilanterol;   Drug: Placebo ACCUHALER/DISKUS;   Drug: Fluticasone propionate/Salmeterol;   Drug: Placebo NDPI
Sponsors:   GlaxoSmithKline;   GlaxoSmithKline
Not yet recruiting – verified April 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Inhaled Beclomethasone Bests Fluticasone (Advair) When HIV PIs Being Used – AIDSmeds.com HIV/AIDS Treatment News

Inhaled Beclomethasone Bests Fluticasone (Advair) When HIV PIs Being Used
AIDSmeds.com HIV/AIDS Treatment News
by Tim Horn Good news for people living with HIV and asthma, bronchitis and chronic obstructive pulmonary disease (COPD). The inhalable steroid beclomethasone can be used at the same time as HIV protease inhibitors without the increased risk of adrenal

View full post on asthma – Google News